MRCAT Brain
MR-RT clinical application
MRCAT Brain
MR-RT clinical application
MRCAT Brain clinical application allows the use of MRI as the primary imaging modality for radiotherapy planning of primary and metastatic tumors in the brain without the need for CT. Detailed anatomical information for contouring and attenuation maps for dose calculations are both obtained from a single, submillimeter resolution 3D T1W mDIXON MR sequence. Artificial Intelligence (AI) is used for fast computation of continuous Hounsfield units directly on the MR console.
Clinical image gallery
- MRCAT-based DRR
- MRCAT Brain with continuous Hounsfield units
- MRCAT source scan (mDIXON XD FFE) and MRCAT-based dose plan
Features
Put Philips MR-only radiotherapy to work today
To successfully bring MR-only radiotherapy into your clinical routine, we recognize that you must look beyond the imaging itself and address important steps such as patient marking, position verification, and quality assurance. We are prepared to support you throughout this process. To this end, we offer dedicated workflow descriptions, best practice sharing and tailored training support, designed to provide assistance as you adopt this new treatment paradigm.
Automatic generation of synthetic CT images using AI
MRCAT Brain uses Artificial Intelligence (AI) for fast computation of MRCAT attenuation maps based on the mDIXON T1W scan. MRCAT generation takes place right on the MR console and provides continuous Hounsfield units for CT-like image appearance.
Short scan time promotes patient comfort and productivity
An MR exam can cause stress for patients. Especially if they are immobilized and in treatment position. The MRCAT source scan is accelerated by Compresses SENSE and takes just a few minutes to complete. This promotes patient comfort by minimizing time in the scanner. Furthermore, it can boost productivity by allowing for additional sequences within the timeslot.
Specifications
- MRCAT Brain
- Compatibility MR system
- Ingenia 1.5T and 3.0T MR-RT, Ambition 1.5T MR-RT and Elition 3.0T MR-RT
Related products
- The Philips Ingenia MR-RT XD platform harnesses the power and value of MRI for radiation therapy planning. It has been designed around the needs of radiation oncology, with ease-of-use, streamlined integration, and versatility in mind. Central to that concept is the ability to define a tailored approach with customizable functionality that meets your individual clinical, workflow, and budgetary requirements – all to provide better patient care.
- As a plug-in clinical application to Ingenia MR-RT, MRCAT Prostate + Auto-Contouring provides attenuation maps and automated, MR-based contours of prostate and organs at risk in as little as 20 minutes – all in a repeatable ‘one-click’ workflow.
- MRCAT Pelvis lets you plan radiation therapy using MRI as a single modality solution. Within just one MR exam, MRCAT Pelvis provides excellent soft-tissue contrast for target and OAR delineation, and continuous Hounsfield units for dose calculations. MRCAT (MR for Calculating ATtenuation) data can be used for export to treatment planning systems for CT-equivalent** dose calculations. In addition, MR-based imaging enables CBCT-based positioning based on soft-tissue contrast with the look and feel of CT.
- MRCAT Head and Neck enables the use of MRI as a primary imaging modality for radiotherapy planning of patients with soft tissue tumors in the Head and Neck, without the need for CT. Powered by AI, MRCAT (MR for Calculating ATtenuation) images with CT-like density information are automatically generated from a single, high-resolution MR scan and can be used for CT-equivalent¹ dose calculations and accurate² patient positioning.
Disclaimer
*Accurate means: MRCAT image acquisition provides < ± 1 mm geometric accuracy of image data in < 20 cm Diameter Spherical Volume (DSV) and < ± 2 mm geometric accuracy of image data in < 40 cm Diameter Spherical Volume (DSV)*. *Limited to 32 cm in z-direction in more than 95% of the points within the volume
**The mean dose in the PTV does not differ more than 1% in MRCAT based plans as compared to CT based plans for 95% of the patient cases
***Accurate means: MRCAT-based DRRs are within 1 mm accuracy compared to CT-based DRRs for 95% of cases